Bright Horizons price target lowered to $112 from $130 at Goldman Sachs

Goldman Sachs lowered the firm’s price target on Bright Horizons (BFAM) to $112 from $130 and keeps a Buy rating on the shares. Bright Horizons delivered mixed Q4 results, beating revenue and earnings estimates but issuing 2026 guidance below Street expectations, the analyst tells investors in a research note. Steady improvements in full-service center occupancy, disciplined pricing, and strong growth in the higher-margin back-up care business support a path toward pre-COVID utilization levels and sustainable, high-quality growth, the firm says.